Bausch Health · conference-presentation
Bausch Health Companies | Results Presentation Deck | 62 slides
62 pages · 0 arc beats · 0 loops
Bausch Health Companies | Results Presentation Deck | 62 slides
Bausch Health · 2023-02 arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
15101520253035404550556062
Deck intelligence map
1 coverage by narrative range · generated from this deck JSON
Narrative range 62 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 62 slides 100% 62/62 slides 100% 62/62 slides · 242 hits — 0/62 slides
43.5% 27/62 slides · 28 hits 3.2% 2/62 slides — 0/62 slides
— 0/62 slides
Slide inventory
62 every slide · same image gating as the playbook
07
The slide uses a 2x2 grid layout to present segment-specific performance data.analyze_data
08
The slide uses a before/after structure (past achievements vs. future outlook) to frame the strategic progress.summarize
11
The slide compares 4Q22 vs 4Q21 revenue performance across three segments.analyze_data
12
The slide compares FY22 vs FY21 revenue figures and growth percentages across three business segments.analyze_data
13
The slide uses donut charts to show revenue composition and lists key drivers for revenue change.analyze_data
14
The slide uses donut charts to represent revenue composition for four distinct business units.analyze_data
15
The slide uses a consistent layout for each segment, showing revenue, reported growth, organic growth, and bulleted performance drivers.analyze_data
16
The slide uses a 2x2 grid layout to present segment-specific financial performance and operational drivers.summarize
17
Includes a bar chart for total revenue and three donut charts for segment breakdowns (Vision Care, Surgical, Ophthalmic Pharmaceuticals).analyze_data
18
The slide compares FY22 and FY21 revenue and provides segment-level breakdowns for Vision Care, Surgical, and Ophthalmic Pharmaceuticals.analyze_data
19
Includes footnotes regarding non-GAAP measures and segment reporting changes.analyze_data
22
Includes detailed footnotes explaining adjustments to cash, debt, and non-GAAP measures.analyze_data
24
The chart uses a stacked bar format to distinguish between Revolver, Term Loans, Mandatory Amortization, Secured Notes, Unsecured Notes, and Intermediate Holdcoanalyze_data
26
The slide uses a waterfall bridge framework to explain the variance between 2022 actuals and 2023 guidance.show_valuation_bridge
27
The slide provides both GAAP and non-GAAP financial metrics and includes detailed footnotes regarding the calculation of interest expenses and the scope of the analyze_data
32
The table compares inventory levels at the end of Q3 and Q4 for two consecutive years.analyze_data
33
The table tracks inventory efficiency over time for specific Bausch Health business units.analyze_data
34
Includes a footnote regarding a gain of $570 million related to an Exchange Offer.analyze_data
35
Includes footnotes regarding non-GAAP measures, share counts, and exclusions for cash flow calculations.analyze_data
36
The table provides a breakdown of financial performance by segment, including a footnote clarifying the definition of segment profit.analyze_data
40
The table details specific line items like amortization, impairments, and restructuring costs, showing their impact on both absolute income and earnings per shaanalyze_data
42
The slide presents two side-by-side tables for Q4 2022 and Q4 2021, detailing various operating expense adjustments.analyze_data
43
The slide presents two side-by-side tables for YTD December 2022 and YTD December 2021.analyze_data
46
The table includes adjustments for exchange rates, divestitures, and discontinuations to arrive at organic revenue figures.analyze_data
47
The table includes adjustments for foreign exchange rates and divestitures to arrive at organic revenue figures.analyze_data
48
Includes footnotes 1, 2, and 3 explaining non-GAAP measures, exchange rate impacts, and segment reporting changes.analyze_data
49
The table provides a detailed breakdown of revenue adjustments including exchange rates and divestitures.analyze_data
50
Includes footnotes regarding non-GAAP measures, exchange rate impacts, and segment reporting changes.analyze_data
51
Includes footnotes regarding non-GAAP measures, currency exchange rates, and segment reporting structure.analyze_data
52
Includes footnotes regarding non-GAAP measures, exchange rates, and segment reporting structure.analyze_data
53
The table reconciles GAAP cash flow from operations to a non-GAAP adjusted figure by adding back specific one-time costs like legal settlements and separation/Ianalyze_data
54
Includes specific adjustments for legal settlements, separation/IPO costs, and exchange offer fees.analyze_data
56
Includes detailed line-item adjustments for impairments, restructuring, and other non-GAAP items.analyze_data
57
Standard financial disclosure slide explaining adjustments like EBITDA, restructuring costs, asset impairments, and share-based compensation.appendix
58
Standard financial disclosure slide explaining the rationale for excluding specific costs from Non-GAAP metrics.appendix
62
Includes definitions for Constant Currency, Adjusted Tax Rate, Adjusted EBITDA excluding Bausch + Lomb, and Adjusted Cash Flows from Operations excluding Bauschappendix